{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:18:41Z","timestamp":1791724721516,"version":"4.3.4"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","award":["PIC\/IC\/83108\/2007"],"award-info":[{"award-number":["PIC\/IC\/83108\/2007"]}]},{"name":"Instituto de Salud Carlos III (ISCIII\/FEDER)","award":["RD12\/0036\/0048"],"award-info":[{"award-number":["RD12\/0036\/0048"]}]},{"name":"Ministerio de Sanidad y Consumo, Madrid, (Spain)"},{"name":"Consejeria Sanidad, Junta de Castilla y Le\u00f3n (Spain)","award":["GRS689\/A\/11"],"award-info":[{"award-number":["GRS689\/A\/11"]}]},{"name":"Consejeria Sanidad, Junta de Castilla y Le\u00f3n (Spain)","award":["GRS909A14"],"award-info":[{"award-number":["GRS909A14"]}]},{"name":"Instituto Biosanitario de Salamanca (IBSAL), Salamanca"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.bbi.2015.07.019","type":"journal-article","created":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T11:24:07Z","timestamp":1437909847000},"page":"1-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":248,"special_numbering":"C","title":["Tumor infiltrating immune cells in gliomas and meningiomas"],"prefix":"10.1016","volume":"53","author":[{"given":"Patr\u00edcia","family":"Domingues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Gonz\u00e1lez-Tablas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juana","family":"Ciudad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Mar\u00eda","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Celeste","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Orfao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Tabernero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2015.07.019_b0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2015.07.019_b0010","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1158\/1078-0432.CCR-09-3087","article-title":"Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy","volume":"16","author":"Alizadeh","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbi.2015.07.019_b0015","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S1470-2045(13)70585-0","article-title":"Clinical use of dendritic cells for cancer therapy","volume":"15","author":"Anguille","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2015.07.019_b0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0303-8467(99)00052-9","article-title":"Fluorescence automatic cell sorter and immunohistochemical investigation of CD68-positive cells in meningioma","volume":"101","author":"Asai","year":"1999","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.bbi.2015.07.019_b0025","doi-asserted-by":"crossref","first-page":"10187","DOI":"10.1523\/JNEUROSCI.3510-08.2008","article-title":"Rod-Shaped monocytes patrol the brain vasculature and give rise to perivascular macrophages under the influence of proinflammatory cytokines and angiopoietin-2","volume":"28","author":"Audoy-Remus","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2015.07.019_b0030","first-page":"7206","article-title":"Immunohistochemical characterization of brain-invasive meningiomas","volume":"7","author":"Backer-Grondahl","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bbi.2015.07.019_b0035","first-page":"957","article-title":"Flow cytometric characterization of tumor-associated macrophages in experimental gliomas","volume":"46","author":"Badie","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1016\/j.bbi.2015.07.019_b0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-5728(01)00361-7","article-title":"Expression of Fas ligand by microglia: possible role in glioma immune evasion","volume":"120","author":"Badie","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2015.07.019_b0045","doi-asserted-by":"crossref","first-page":"e80908","DOI":"10.1371\/journal.pone.0080908","article-title":"Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages","volume":"8","author":"Barros","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.bbi.2015.07.019_b0050","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.4049\/jimmunol.169.11.6141","article-title":"Different efficiency of heat shock proteins (HSP) to activate human monocytes and dendritic cells: superiority of HSP60","volume":"169","author":"Bethke","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2015.07.019_b0055","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/eji.200838921","article-title":"Site-specific anti-tumor immunity: differences in DC function, TGF-beta production and numbers of intratumoral Foxp3+ Treg","volume":"39","author":"Biollaz","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbi.2015.07.019_b0060","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbi.2015.07.019_b0065","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-12-3314","article-title":"Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages","author":"Bloch","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbi.2015.07.019_b0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/B:NEON.0000027751.87894.f0","article-title":"Expression of G-CSF and GM-CSF in human meningiomas correlates with increased tumor proliferation and vascularization","volume":"68","author":"Braun","year":"2004","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0075","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/1097-0142(20010715)92:2<420::AID-CNCR1338>3.0.CO;2-3","article-title":"A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma","volume":"92","author":"Buckner","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.bbi.2015.07.019_b0080","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1017\/S1092852900014000","article-title":"Brain lesions manifesting as psychiatric disorders: eight cases","volume":"13","author":"Bunevicius","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.bbi.2015.07.019_b0085","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1593\/neo.11024","article-title":"B cells are critical to T-cell-mediated antitumor immunity induced by a combined immune-stimulatory\/conditionally cytotoxic therapy for glioblastoma","volume":"13","author":"Candolfi","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbi.2015.07.019_b0090","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1200\/JCO.2000.18.10.2143","article-title":"Early depressive symptoms in cancer patients receiving interleukin 2 and\/or interferon alfa-2b therapy","volume":"18","author":"Capuron","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0095","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/sj.mp.4000995","article-title":"Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy","volume":"7","author":"Capuron","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2015.07.019_b0100","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.4049\/jimmunol.0802845","article-title":"NK cells recognize and kill human glioblastoma cells with stem cell-like properties","volume":"182","author":"Castriconi","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2015.07.019_b0105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ymeth.2012.03.027","article-title":"Emerging applications of flow cytometry in solid tumor biology","volume":"57","author":"Chang","year":"2012","journal-title":"Methods"},{"issue":"123","key":"10.1016\/j.bbi.2015.07.019_b0110","first-page":"E26","article-title":"Glioblastoma multiforme presenting as treatment-resistant depression","volume":"22","author":"Cheema","year":"2010","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2015.07.019_b0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/neuonc\/nop009","article-title":"TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients","volume":"12","author":"Crane","year":"2010","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0120","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-012-1018-0","article-title":"Brain dendritic cells: biology and pathology","volume":"124","author":"D\u2019Agostino","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2015.07.019_b0125","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1749-6632.2001.tb05827.x","article-title":"Cytokine-induced sickness behavior: mechanisms and implications","volume":"933","author":"Dantzer","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbi.2015.07.019_b0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2015.07.019_b0135","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ni.2705","article-title":"Tissue-resident macrophages","volume":"14","author":"Davies","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbi.2015.07.019_b0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/cyto.b.20603","article-title":"Flow cytometric characterization of cerebrospinal fluid cells","volume":"80","author":"de Graaf","year":"2011","journal-title":"Cytometry B Clin. Cytom."},{"key":"10.1016\/j.bbi.2015.07.019_b0145","first-page":"1253","article-title":"Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin","volume":"1","author":"Debinski","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbi.2015.07.019_b0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00401-014-1321-z","article-title":"Microglia as a critical player in both developmental and late-life CNS pathologies","volume":"128","author":"Derecki","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2015.07.019_b0155","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1084\/jem.20050640","article-title":"Blocking IL-1 in systemic inflammation","volume":"201","author":"Dinarello","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2015.07.019_b0160","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.ajpath.2012.07.033","article-title":"Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas","volume":"181","author":"Domingues","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbi.2015.07.019_b0165","article-title":"The protein expression profile of meningioma cells is associated with distinct cytogenetic tumour subgroups","author":"Domingues","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbi.2015.07.019_b0170","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/neuonc\/not325","article-title":"Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype","volume":"16","author":"Domingues","year":"2014","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0175","first-page":"12","article-title":"Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human glioma","volume":"7","author":"Dunn","year":"2007","journal-title":"Cancer Immun."},{"key":"10.1016\/j.bbi.2015.07.019_b0180","doi-asserted-by":"crossref","first-page":"e47045","DOI":"10.1371\/journal.pone.0047045","article-title":"The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer","volume":"7","author":"Edin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2015.07.019_b0185","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1215\/15228517-2006-006","article-title":"An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme","volume":"8","author":"El Andaloussi","year":"2006","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11060-006-9314-y","article-title":"CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas","volume":"83","author":"El Andaloussi","year":"2007","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0195","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11060-005-9092-y","article-title":"Chordoid meningioma, an uncommon variant of meningioma: a clinicopathologic study of 12 cases","volume":"78","author":"Epari","year":"2006","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0200","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/neuonc\/not110","article-title":"The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells","volume":"15","author":"Fang","year":"2013","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0205","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11910-013-0337-4","article-title":"Meningioma","volume":"13","author":"Fathi","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.bbi.2015.07.019_b0210","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/neuonc\/nor229","article-title":"Systematic review of supportive care needs in patients with primary malignant brain tumors","volume":"14","author":"Ford","year":"2012","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0215","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbi.2015.07.019_b0220","doi-asserted-by":"crossref","first-page":"e23902","DOI":"10.1371\/journal.pone.0023902","article-title":"Characteristics of the alternative phenotype of microglia\/macrophages and its modulation in experimental gliomas","volume":"6","author":"Gabrusiewicz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2015.07.019_b0225","doi-asserted-by":"crossref","first-page":"8874","DOI":"10.1158\/0008-5472.CAN-07-0177","article-title":"Increased glioma growth in mice depleted of macrophages","volume":"67","author":"Galarneau","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbi.2015.07.019_b0230","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1200\/JCO.2008.20.5765","article-title":"Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial","volume":"27","author":"Gehring","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0235","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jneuroim.2013.09.001","article-title":"Phenotypical analysis, relation to malignancy and prognostic relevance of ICOS+T regulatory and dendritic cells in patients with gliomas","volume":"264","author":"Gousias","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2015.07.019_b0240","first-page":"2965","article-title":"Neurobehavioural changes in patients following brain tumour: patients and relatives perspective","volume":"22","author":"Gregg","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bbi.2015.07.019_b0245","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2990.2008.00960.x","article-title":"The microglial\/macrophagic response at the tumour-brain border of invasive meningiomas","volume":"35","author":"Grund","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbi.2015.07.019_b0250","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1189\/jlb.0303114","article-title":"Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification","volume":"75","author":"Guillemin","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbi.2015.07.019_b0255","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20080108","article-title":"\u201cRe-educating\u201d tumor-associated macrophages by targeting NF-kappaB","volume":"205","author":"Hagemann","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2015.07.019_b0260","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mcn.2012.10.004","article-title":"Role of the systemic immune system in brain metastasis","volume":"53","author":"Hamilton","year":"2013","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.bbi.2015.07.019_b0265","doi-asserted-by":"crossref","first-page":"948098","DOI":"10.1155\/2012\/948098","article-title":"Macrophages in tumor microenvironments and the progression of tumors","volume":"2012","author":"Hao","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.bbi.2015.07.019_b0270","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/oli.2006.0053","article-title":"Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I\/II studies","volume":"17","author":"Hau","year":"2007","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.bbi.2015.07.019_b0275","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1040-8428(01)00122-6","article-title":"Adoptive cellular immunotherapy for the treatment of malignant gliomas","volume":"39","author":"Hayes","year":"2001","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"10.1016\/j.bbi.2015.07.019_b0280","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1158\/1078-0432.CCR-08-0320","article-title":"Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas","volume":"14","author":"Heimberger","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbi.2015.07.019_b0285","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1158\/1535-7163.737.3.6","article-title":"SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility","volume":"3","author":"Hjelmeland","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbi.2015.07.019_b0290","doi-asserted-by":"crossref","first-page":"e63933","DOI":"10.1371\/journal.pone.0063933","article-title":"Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumours","volume":"8","author":"Hoepner","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.bbi.2015.07.019_b0295","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1158\/0008-5472.CAN-13-1072","article-title":"Oligodendrocyte progenitor cells promote neovascularization in glioma by disrupting the blood-brain barrier","volume":"74","author":"Huang","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbi.2015.07.019_b0300","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1215\/15228517-2006-008","article-title":"The role of human glioma-infiltrating microglia\/macrophages in mediating antitumor immune responses","volume":"8","author":"Hussain","year":"2006","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0305","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1479-5876-4-15","article-title":"Innate immune functions of microglia isolated from human glioma patients","volume":"4","author":"Hussain","year":"2006","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbi.2015.07.019_b0310","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1158\/0008-5472.CAN-07-1243","article-title":"A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients","volume":"67","author":"Hussain","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbi.2015.07.019_b0315","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","article-title":"From monocytes to M1\/M2 macrophages: phenotypical vs. functional differentiation","volume":"5","author":"Italiani","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2015.07.019_b0320","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1215\/15228517-2008-104","article-title":"Regulatory T cells and the PD-L1\/PD-1 pathway mediate immune suppression in malignant human brain tumors","volume":"11","author":"Jacobs","year":"2009","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0325","doi-asserted-by":"crossref","first-page":"7983","DOI":"10.1158\/0008-5472.CAN-07-1493","article-title":"Expression of interleukin-13 receptor alpha2 in glioblastoma multiforme: implications for targeted therapies","volume":"67","author":"Jarboe","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbi.2015.07.019_b0330","doi-asserted-by":"crossref","first-page":"15871","DOI":"10.1073\/pnas.2036503100","article-title":"Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478","volume":"100","author":"Johns","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2015.07.019_b0335","doi-asserted-by":"crossref","first-page":"937253","DOI":"10.1155\/2012\/937253","article-title":"Modulation of tumor tolerance in primary central nervous system malignancies","volume":"2012","author":"Johnson","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.bbi.2015.07.019_b0340","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF03262077","article-title":"HER-2\/neu assessment in breast cancer by immunohistochemistry and fluorescence in situ hybridization: comparison of results and correlation with survival","volume":"5","author":"Kakar","year":"2000","journal-title":"Mol. Diagn."},{"key":"10.1016\/j.bbi.2015.07.019_b0345","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00011.2010","article-title":"Physiology of microglia","volume":"91","author":"Kettenmann","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbi.2015.07.019_b0350","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/icb.2013.29","article-title":"Myeloid-derived suppressor cells in cancer: recent progress and prospects","volume":"91","author":"Khaled","year":"2013","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.bbi.2015.07.019_b0355","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/02688697.2011.584986","article-title":"Tumour-infiltrating T-cell subpopulations in glioblastomas","volume":"26","author":"Kim","year":"2012","journal-title":"Br. J. Neurosurg."},{"key":"10.1016\/j.bbi.2015.07.019_b0360","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneuroim.2013.08.013","article-title":"Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level","volume":"264","author":"Kmiecik","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2015.07.019_b0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-013-1265-5","article-title":"Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours","volume":"116","author":"Kmiecik","year":"2014","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0370","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3109\/08820139.2012.689591","article-title":"Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development","volume":"41","author":"Kohanbash","year":"2012","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.bbi.2015.07.019_b0375","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/path.2370","article-title":"Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas","volume":"216","author":"Komohara","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbi.2015.07.019_b0380","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00415-013-7145-2","article-title":"Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases","volume":"261","author":"Kowarik","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbi.2015.07.019_b0385","first-page":"1513","article-title":"Th1\/Th2 cytokine imbalance in meningioma, anaplastic astrocytoma and glioblastoma multiforme patients","volume":"15","author":"Kumar","year":"2006","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbi.2015.07.019_b0390","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2006.08.1117","article-title":"Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group","volume":"25","author":"Kunwar","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0395","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/neuonc\/nop054","article-title":"Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma","volume":"12","author":"Kunwar","year":"2010","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0400","first-page":"1","article-title":"Beyond laser microdissection technology: follow the yellow brick road for cancer research","volume":"4","author":"Legres","year":"2014","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bbi.2015.07.019_b0405","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1158\/1078-0432.CCR-10-2557","article-title":"Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-beta","volume":"17","author":"Lohr","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbi.2015.07.019_b0410","first-page":"535","article-title":"Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions","volume":"19","author":"Lossinsky","year":"2004","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.bbi.2015.07.019_b0415","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2015.07.019_b0420","doi-asserted-by":"crossref","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2015.07.019_b0425","doi-asserted-by":"crossref","first-page":"952469","DOI":"10.1155\/2013\/952469","article-title":"Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brain","volume":"2013","author":"Maes","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.bbi.2015.07.019_b0430","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1200\/JCO.2010.30.5037","article-title":"Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer","volume":"29","author":"Mahmoud","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0435","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2005.10.001","article-title":"Macrophage polarization comes of age","volume":"23","author":"Mantovani","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.bbi.2015.07.019_b0440","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(08)60241-X","article-title":"Tumour immunity: effector response to tumour and role of the microenvironment","volume":"371","author":"Mantovani","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2015.07.019_b0445","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4137\/BMI.S2185","article-title":"Immunohistochemistry as an important tool in biomarkers detection and clinical practice","volume":"5","author":"Matos","year":"2010","journal-title":"Biomarker Insights"},{"key":"10.1016\/j.bbi.2015.07.019_b0450","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/sj.bjc.6602089","article-title":"Recombinant humanised anti-HER2\/neu antibody (Herceptin) induces cellular death of glioblastomas","volume":"91","author":"Mineo","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbi.2015.07.019_b0455","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fimmu.2014.00603","article-title":"TH1\/TH2 paradigm extended: macrophage polarization as an unappreciated pathogen-driven escape mechanism?","volume":"5","author":"Muraille","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2015.07.019_b0460","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.4049\/jimmunol.1001323","article-title":"CD20+ B cells: the other tumor-infiltrating lymphocytes","volume":"185","author":"Nelson","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2015.07.019_b0465","first-page":"1621","article-title":"Tumor-associated macrophage\/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1","volume":"34","author":"Okada","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0470","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1200\/JCO.2010.30.7744","volume":"29","author":"Okada","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0475","first-page":"2851","article-title":"Identification of a novel HLA-A\u22170201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain","volume":"8","author":"Okano","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbi.2015.07.019_b0480","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11060-008-9660-z","article-title":"Phase I analysis of BCNU-impregnated biodegradable polymer wafers followed by systemic interferon alfa-2b in adults with recurrent glioblastoma multiforme","volume":"90","author":"Olson","year":"2008","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0485","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nn.3161","article-title":"Immune surveillance in the central nervous system","volume":"15","author":"Ousman","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbi.2015.07.019_b0490","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1200\/JCO.2008.19.6147","article-title":"In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer","volume":"27","author":"Pages","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0495","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3171\/2008.7.JNS08475","article-title":"Flow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation","volume":"110","author":"Parney","year":"2009","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.bbi.2015.07.019_b0500","first-page":"3355","article-title":"Monoclonal antibody cetuximab binds to and down-regulates constitutively activated epidermal growth factor receptor vIII on the cell surface","volume":"27","author":"Patel","year":"2007","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbi.2015.07.019_b0505","doi-asserted-by":"crossref","first-page":"6390","DOI":"10.1158\/1078-0432.CCR-04-2653","article-title":"Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity","volume":"11","author":"Perera","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbi.2015.07.019_b0510","doi-asserted-by":"crossref","first-page":"E415","DOI":"10.1073\/pnas.1211850110","article-title":"Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery","volume":"110","author":"Predina","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2015.07.019_b0515","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00401-014-1267-1","article-title":"Microglia: unique and common features with other tissue macrophages","volume":"128","author":"Prinz","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2015.07.019_b0520","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.3337","article-title":"CSF-1R inhibition alters macrophage polarization and blocks glioma progression","volume":"19","author":"Pyonteck","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2015.07.019_b0525","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2015.07.019_b0530","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1200\/JCO.2008.17.7089","article-title":"Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin\u2019s lymphoma: improved sensitivity of flow cytometry","volume":"27","author":"Quijano","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0535","first-page":"2157","article-title":"Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma","volume":"6","author":"Rand","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbi.2015.07.019_b0540","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/neuonc\/nor042","article-title":"Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma","volume":"13","author":"Raychaudhuri","year":"2011","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0545","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/neuonc\/nop023","article-title":"Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties","volume":"12","author":"Rodrigues","year":"2010","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0550","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s101430050017","article-title":"Expression of BCL-2 oncoprotein on tumor cells and tumor-infiltrating lymphocytes (TIL) in meningiomas","volume":"22","author":"Roessler","year":"1999","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.bbi.2015.07.019_b0555","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.bbi.2012.01.016","article-title":"Central nervous system: a modified immune surveillance circuit?","volume":"26","author":"Romo-Gonzalez","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2015.07.019_b0560","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1073\/pnas.130166597","article-title":"Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors","volume":"97","author":"Sampson","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2015.07.019_b0565","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1200\/JCO.2010.28.6963","article-title":"Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma","volume":"28","author":"Sampson","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0570","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/glia.20201","article-title":"Impaired capacity for upregulation of MHC class II in tumor-associated microglia","volume":"51","author":"Schartner","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2015.07.019_b0575","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/neuonc\/nou348","article-title":"A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study","volume":"17","author":"Schuster","year":"2015","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0580","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1073\/pnas.0611693104","article-title":"A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors","volume":"104","author":"Scott","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2015.07.019_b0585","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuron.2009.11.032","article-title":"Dual roles for perivascular macrophages in immune-to-brain signaling","volume":"65","author":"Serrats","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.bbi.2015.07.019_b0590","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.4049\/jimmunol.1003460","article-title":"Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase","volume":"187","author":"Sharda","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2015.07.019_b0595","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1101\/gad.169029.111","article-title":"Immune microenvironments in solid tumors: new targets for therapy","volume":"25","author":"Shiao","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbi.2015.07.019_b0600","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1186\/1471-2407-12-561","article-title":"Profound tumor-specific Th2 bias in patients with malignant glioma","volume":"12","author":"Shimato","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbi.2015.07.019_b0605","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/path.4192","article-title":"Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response","volume":"230","author":"Sielska","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbi.2015.07.019_b0610","first-page":"37","article-title":"Immune cell infiltration of intrinsic and metastatic intracranial tumours","volume":"24","author":"Strik","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbi.2015.07.019_b0615","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1038\/cddis.2013.562","article-title":"Interleukin-1beta promotes hypoxia-induced apoptosis of glioblastoma cells by inhibiting hypoxia-inducible factor-1 mediated adrenomedullin production","volume":"5","author":"Sun","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbi.2015.07.019_b0620","doi-asserted-by":"crossref","first-page":"e0116644","DOI":"10.1371\/journal.pone.0116644","article-title":"Glioma-associated microglia\/macrophages display an expression profile different from m1 and m2 polarization and highly express gpnmb and spp1","volume":"10","author":"Szulzewsky","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.bbi.2015.07.019_b0625","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1474-4422(04)00680-5","article-title":"Cognitive deficits in adult patients with brain tumours","volume":"3","author":"Taphoorn","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2015.07.019_b0630","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cellimm.2013.07.013","article-title":"Cytotoxic activity of ex-vivo generated IFNalpha-induced monocyte-derived dendritic cells in brain glioma patients","volume":"284","author":"Tyrinova","year":"2013","journal-title":"Cell Immunol."},{"key":"10.1016\/j.bbi.2015.07.019_b0635","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1189\/jlb.0907611","article-title":"Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes\/macrophages that bear M1- and M2-type characteristics","volume":"83","author":"Umemura","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbi.2015.07.019_b0640","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"van Dongen","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bbi.2015.07.019_b0645","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/14728214.2012.679929","article-title":"Recent developments on immunotherapy for brain cancer","volume":"17","author":"Wainwright","year":"2012","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.bbi.2015.07.019_b0650","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1158\/1078-0432.CCR-14-0514","article-title":"Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors","volume":"20","author":"Wainwright","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbi.2015.07.019_b0655","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bbrc.2008.04.055","article-title":"Hypoxia enhances CXCR4 expression favoring microglia migration via HIF-1alpha activation","volume":"371","author":"Wang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbi.2015.07.019_b0660","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.4049\/jimmunol.180.11.7673","article-title":"Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastoma","volume":"180","author":"Waziri","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2015.07.019_b0665","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbi.2015.07.019_b0670","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1158\/1078-0432.CCR-06-2399","article-title":"Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab","volume":"13","author":"Wu","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbi.2015.07.019_b0675","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2015.07.019_b0680","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.bbi.2010.08.004","article-title":"IL-10 within the CNS is necessary for CD4+ T cells to mediate neuroprotection","volume":"25","author":"Xin","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2015.07.019_b0685","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1158\/1078-0432.CCR-06-0141","article-title":"Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4","volume":"12","author":"Yang","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbi.2015.07.019_b0690","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jocn.2009.05.006","article-title":"The role of microglia in central nervous system immunity and glioma immunology","volume":"17","author":"Yang","year":"2010","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.bbi.2015.07.019_b0695","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3171\/2011.4.JNS101172","article-title":"Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology","volume":"115","author":"Yang","year":"2011","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.bbi.2015.07.019_b0700","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.immuni.2011.03.014","article-title":"B7-h2 is a costimulatory ligand for CD28 in human","volume":"34","author":"Yao","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.bbi.2015.07.019_b0705","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1024933925645","article-title":"Intratumoral T cell subset ratios and Fas ligand expression on brain tumor endothelium","volume":"64","author":"Yu","year":"2003","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.bbi.2015.07.019_b0710","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jocn.2005.10.011","article-title":"Survival of glioblastoma patients related to presenting symptoms, brain site and treatment variables","volume":"13","author":"Yuile","year":"2006","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.bbi.2015.07.019_b0715","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cyto.2007.05.012","article-title":"Comparative analysis of peripheral and localised cytokine secretion in glioblastoma patients","volume":"39","author":"Zisakis","year":"2007","journal-title":"Cytokine"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159115004146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159115004146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:43:56Z","timestamp":1760168636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159115004146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":143,"alternative-id":["S0889159115004146"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2015.07.019","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor infiltrating immune cells in gliomas and meningiomas","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2015.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}